Partillion Bioscience Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5M
- Investors
-
6
Partillion Bioscience General Information
Description
Developer of the biology reagent platform designed for broadening access to advanced single-cell assays. The company's novel nano vial platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological functions such as secreted proteins, enabling biotech labs and clients to develop higher-performing therapies for cancer, autoimmune conditions, and infectious diseases.
Contact Information
Website
www.partillion.comCorporate Office
- 1927 Paseo Rancho Castilla
- Los Angeles, CA 90032
- United States
Corporate Office
- 1927 Paseo Rancho Castilla
- Los Angeles, CA 90032
- United States
Partillion Bioscience Timeline
Partillion Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 26-Sep-2023 | $5M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Seed Round | 30-Dec-2022 | $4.87M | $4.87M | Completed | Generating Revenue | |
| 1. Grant | 16-Sep-2021 | $1.07M | Completed | Generating Revenue |
Partillion Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Partillion Bioscience Comparisons
Industry
Financing
Details
Partillion Bioscience Competitors (18)
One of Partillion Bioscience’s 18 competitors is New England Biolabs, a Corporation company based in Ipswich, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| New England Biolabs | Corporation | Ipswich, MA | ||||
| Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | ||||
| Proteros biostructures | Private Equity-Backed | Martinsried, Germany | ||||
| Cell Signaling Technology | Corporation | Danvers, MA | ||||
| Cellectis | Formerly VC-backed | Paris, France |
Partillion Bioscience Patents
Partillion Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022258444-A1 | Nanoscale reaction chambers and methods of using the same | Pending | 14-Apr-2021 | ||
| CA-3215070-A1 | Nanoscale reaction chambers and methods of using the same | Pending | 14-Apr-2021 | ||
| EP-4323542-A1 | Nanoscale reaction chambers and methods of using the same | Pending | 14-Apr-2021 | ||
| EP-4323542-A4 | Nanoscale reaction chambers and methods of using the same | Pending | 14-Apr-2021 | ||
| US-12503723-B1 | Nanoscale reaction chambers and methods of using the same | Active | 14-Apr-2021 | G01N33/6854 |
Partillion Bioscience Signals
Partillion Bioscience Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ND Capital | Venture Capital | Minority | ||
| Paladin Capital Group | Venture Capital | Minority | ||
| Vertical Venture Partners | Venture Capital | Minority | ||
| US National Science Foundation | Accelerator/Incubator | |||
| General Inception | Venture Capital | Minority |
Partillion Bioscience FAQs
-
When was Partillion Bioscience founded?
Partillion Bioscience was founded in 2020.
-
Where is Partillion Bioscience headquartered?
Partillion Bioscience is headquartered in Los Angeles, CA.
-
What is the size of Partillion Bioscience?
Partillion Bioscience has 15 total employees.
-
What industry is Partillion Bioscience in?
Partillion Bioscience’s primary industry is Biotechnology.
-
Is Partillion Bioscience a private or public company?
Partillion Bioscience is a Private company.
-
What is Partillion Bioscience’s current revenue?
The current revenue for Partillion Bioscience is .
-
How much funding has Partillion Bioscience raised over time?
Partillion Bioscience has raised $9.9M.
-
Who are Partillion Bioscience’s investors?
ND Capital, Paladin Capital Group, Vertical Venture Partners, US National Science Foundation, and General Inception are 5 of 6 investors who have invested in Partillion Bioscience.
-
Who are Partillion Bioscience’s competitors?
New England Biolabs, Nanion Technologies, Proteros biostructures, Cell Signaling Technology, and Cellectis are some of the 18 competitors of Partillion Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process